pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
AMB-051
Tenosynovial Giant Cell Tumor
AmMax Bio Inc
0
catalysts
Preclinical
AMB-304
Colorectal Cancer
AimedBio Inc
0
catalysts
Preclinical
AMI-463
Childhood Rhabdomyosarcoma
Amira Therapeutics SL
0
catalysts
Preclinical
AMP-105
Head And Neck Squamous Cell Carcinoma (HNSC)
Amphastar Pharmaceuticals, Inc.
← prev
page 9 of 62
next →
131
Pain
89
Neurology
1
$AMPH
0
catalysts
Preclinical
AMP-109
Colorectal Cancer
$AMPH
Amphastar Pharmaceuticals, Inc.
0
catalysts
Phase 1
AMT-754
Bladder Cancer
ADCendo ApS
0
catalysts
Preclinical
AMX-883
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Amphista Therapeutics Ltd
0
catalysts
Phase 1
AN-4005
Diffuse Large B-Cell Lymphoma
Adlai Nortye Biopharma Co Ltd
0
catalysts
Phase 1
AN-9025
Bile Duct Cancer (Cholangiocarcinoma)
Adlai Nortye Biopharma Co Ltd
0
catalysts
Phase 1
AND-019
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Kind Pharmaceuticals
0
catalysts
Phase 2
ANS-01
Non-Small Cell Lung Cancer
Avistone Biotechnology Co Ltd
0
catalysts
Phase 1
ANS-03
Solid Tumor
Avistone Biotechnology Co Ltd
0
catalysts
Preclinical
ANT-308 Fc3
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Cambium Oncology LLC
0
catalysts
Preclinical
ANV-221
Pancreatic Cancer
Anviron Corp
0
catalysts
Phase 2
ANV-419
Metastatic Melanoma
Anaveon AG
0
catalysts
Phase 2
ANV-600
Melanoma
Anaveon AG
0
catalysts
Preclinical
AP-001
Metavert
Pancreatic Cancer
Avenzoar Pharmaceuticals Inc
0
catalysts
Phase 2
AP-030
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Apollo Therapeutics Ltd
0
catalysts
Phase 2
APG-157
Squamous Cell Carcinoma
Aveta Biomics Inc
0
catalysts
Preclinical
APG-3526
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
0
catalysts
Phase 1
APG-5918
Castration-Resistant Prostate Cancer (CRPC)
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
0
catalysts
Preclinical
APL-1501
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Asieris Pharmaceuticals (USA) Inc
0
catalysts
Phase 2
APL-2302
Breast Cancer
Asieris Pharmaceuticals (USA) Inc
0
catalysts
Phase 1
APN-401
Head And Neck Squamous Cell Carcinoma (HNSC)
InvIOs GmbH
0
catalysts
Phase 1
APR-1051
Breast Cancer
$APRE
Aprea Therapeutics, Inc.
0
catalysts
Phase 2
APS-03118
Medullary Thyroid Cancer
Applied Pharmaceutical Science Inc
0
catalysts
Preclinical
APT-002
Glioblastoma Multiforme (GBM)
Aptah Bio Inc
0
catalysts
Phase 2
APTA-16
Myelodysplastic Syndrome (Preleukemia)
AptaBio Therapeutics Inc
0
catalysts
Preclinical
AQ-004
Lung Cancer
Aquilon Pharmaceuticals SA
0
catalysts
Preclinical
AR-170
Solid Tumor
Y-Biologics Inc
0
catalysts
